J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on July 1, 2005

Papers In Press, published online ahead of print April 16, 2005
J. Lipid Res., doi:10.1194/jlr.M500085-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M500085-JLR200v1
46/7/1405    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parks, B. W.
Right arrow Articles by Kabarowski, J. H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parks, B. W.
Right arrow Articles by Kabarowski, J. H. S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on March 1, 2005
Revised on March 28, 2005
Accepted on April 12, 2005

Loss of G2A promotes macrophage accumulation in atherosclerotic lesions of low-density lipoprotein receptor-deficient mice

Brian W. Parks, Ginger P. Gambill, Aldons J. Lusis, and Janusz H. S. Kabarowski

Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294-2170

Corresponding Author: janusz{at}uab.edu

Lysophosphatidylcholine is considered a major pro-atherogenic component of oxidized low-density lipoprotein based on its pro-inflammatory actions in vitro. Lysophosphatidylcholine stimulates macrophage and T cell chemotaxis via the G protein-coupled receptor G2A and may thus promote inflammatory cell infiltration during atherosclerotic lesion development. However, G2A also mediates pro-apoptotic effects of lysophosphatidylcholine and may therefore promote death of inflammatory cells within developing lesions. To determine how these effects of lysophosphatidylcholine modify atherogenesis, we examined atherosclerotic lesion development in G2A-sufficient and G2A-deficient low-density lipoprotein receptor knockout mice. Although lysophosphatidylcholine species capable of activating G2A-dependent responses were increased during lesion development, G2A-deficient mice developed lesions similar in size to those in their G2A-sufficient counterparts. Loss of G2A during atherosclerotic lesion development did not reduce macrophage and T cell infiltration but instead resulted in increased lesional macrophage content associated with reduced numbers of terminal deoxynucleotidyl transferase-mediated dUTP nick end labeled cells and decreased collagen deposition. These data indicate that the ability of lysophosphatidylcholine to stimulate macrophage and T cell chemotaxis via G2A is not manifested in vivo and G2A-mediated pro-apoptotic rather than chemotactic action is most penetrant during atherogenesis and may modify the stability of atherosclerotic lesions by promoting macrophage death.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
S. C. Frasch, K. Zemski-Berry, R. C. Murphy, N. Borregaard, P. M. Henson, and D. L. Bratton
Lysophospholipids of Different Classes Mobilize Neutrophil Secretory Vesicles and Induce Redundant Signaling through G2A
J. Immunol., May 15, 2007; 178(10): 6540 - 6548.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
D. T. Bolick, A. M. Whetzel, M. Skaflen, T. L. Deem, J. Lee, and C. C. Hedrick
Absence of the G Protein-Coupled Receptor G2A in Mice Promotes Monocyte/Endothelial Interactions in Aorta
Circ. Res., March 2, 2007; 100(4): 572 - 580.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
B. W. Parks, A. J. Lusis, and J. H.S. Kabarowski
Loss of the Lysophosphatidylcholine Effector, G2A, Ameliorates Aortic Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice
Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2703 - 2709.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
D. Namgaladze and B. Brune
Phospholipase A2-Modified Low-Density Lipoprotein Activates the Phosphatidylinositol 3-Kinase-Akt Pathway and Increases Cell Survival in Monocytic Cells
Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2510 - 2516.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.